Disclosure of investigators' recruitment performance in multicenter clinical trials: a further step for research transparency.
Résumé
Rafael Dal-Ré and colleagues argue that the recruitment targets and performance of all site investigators in multi-centre clinical trials should be disclosed in trial registration sites before a trial starts, and when it ends.
Domaines
Santé publique et épidémiologieOrigine | Fichiers éditeurs autorisés sur une archive ouverte |
---|
Loading...